Encounter Resources Limited (ASX: ENR) has reported continued success from aircore drilling at the Green Prospect, part of the Aileron Project in the West Arunta region of Western Australia (Figure 1). Recent drilling has confirmed the extension of shallow, high-grade niobium mineralisation east of the existing Green Mineral Resource Estimate (MRE), reinforcing the scale and continuity of this emerging carbonatite-hosted niobium system.

Viking Mines Limited (ASX: VKA) has announced the acquisition of a high-grade, production-proven tungsten portfolio in Nevada, USA, a Tier-1 mining jurisdiction (Figure 1). The transaction provides Viking with 100% exposure to six historical tungsten projects located in close proximity to strategic US defence infrastructure, positioning the Company within a critical minerals supply chain at a time of heightened geopolitical urgency.

archTIS Limited (ASX: AR9) has provided a detailed update on its progress with the United States Department of Defense (U.S. DoD), highlighting the successful production deployment of its NC Protect software within the Microsoft DoD365 environment. The update also outlines renewed licenses, customised development work, and new non-dilutive funding aimed at accelerating U.S. market penetration. The core activities are centred in the United States, with archTIS headquartered in

Algorae Pharmaceuticals Limited (ASX: 1AI) has taken another step in building its commercial presence within the Australian pharmaceutical market. The Company has entered into a distribution agreement with Dr. Reddy’s Laboratories Ltd (NSE: DRREDDY), marking a strategic shift from purely into tangible near-term revenue generation. The first shipment of Capecitabine 500mg tablets is scheduled to arrive in Australia in December 2025, positioning Algorae for an accelerated comme

Critical Resources Limited (ASX: CRR) continues to position its Mavis Lake Lithium Project in northwestern Ontario as one of the more advanced hard-rock lithium assets in the region (Figure 1). The Company has expanded its landholding by 25% to more than 400 km², strengthened its geological footprint, and advanced exploration to position the Project as a future supplier to the North American battery supply chain.

IRIS Metals Limited (ASX: IR1) has secured an exclusive right to farm-in to the Finley Basin Tungsten Project, located in Granite County, Montana, USA, through a binding Heads of Agreement with Finley Mining Inc and its shareholders. The transaction provides IRIS with entry into a historically high-grade tungsten system within a mining-friendly U.S. jurisdiction, aligning with its broader critical minerals strategy and U.S.-focused asset base.

Cyclone Metals is advancing early-stage gold exploration within structurally prospective ground in Central Otago. The Company holds a 100% interest in both the Waikerikeri and Drybread permits, which lie proximal to established gold systems, including Santana Minerals’ Rise & Shine project and OceanaGold’s Macraes Flat operation. These projects are positioned along major regional structures, notably the Dunstan Range Fault, a recognised control on gold mineralisation in the r

The discussion focused on tungsten, antimony, and gold, but more importantly, on mineral systems thinking—how deposits form, why certain geological settings matter, and why Pioneer’s ground selection in Idaho, USA, was anything but random. As someone who has followed tungsten closely, this was a conversation that went well beyond commodity hype and into the fundamentals of discovery.

DevEx Resources Ltd (ASX: DEV) has reported new heap leach column test results that materially enhance the extraction outlook for critical Magnetic Rare Earth Elements (MREEs) from the Kennedy ionic clay-hosted system. The Kennedy Rare Earths Project, located in North Queensland approximately 50km south of Mount Garnet and connected to Townsville’s port and infrastructure corridor, has delivered a significant step forward in its metallurgical understanding.

Echo IQ Limited (ASX: EIQ), based in Sydney, has released new clinical insights presented at the AHA Scientific Sessions 2025 in New Orleans, highlighting the growing medical need and commercial opportunity for EchoSolv AS, the Company’s AI-powered decision-support tool for severe aortic stenosis (AS).